SELLAS Life Sciences Group, Inc - stock earnings
SLS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -9.3 million USD | ? USD |
| 2023Q2 | -8.8 million USD | ? USD |
| 2023Q1 | -10.9 million USD | ? USD |
| 2022Q4 | -8.6 million USD | -1.0 million USD |
| 2022Q3 | -6.8 million USD | ? USD |
| 2022Q2 | -8.2 million USD | ? USD |
| 2022Q1 | -16.8 million USD | 1.0 million USD |
| 2021Q4 | -6.6 million USD | -7.6 million USD |
| 2021Q3 | -7.1 million USD | ? USD |
| 2021Q2 | -4.6 million USD | 1.9 million USD |
| 2021Q1 | -2.4 million USD | 5.7 million USD |
| 2020Q4 | -3.7 million USD | 1.9 million USD |
| 2020Q3 | -4.5 million USD | ? USD |
| 2020Q2 | -4.4 million USD | ? USD |
| 2020Q1 | -4.1 million USD | ? USD |
| 2019Q4 | -7.4 million USD | ? USD |
| 2019Q3 | -4.2 million USD | ? USD |
| 2019Q2 | -3.1 million USD | ? USD |
| 2019Q1 | -4.5 million USD | ? USD |
| 2018Q4 | -13.3 million USD | ? USD |
| 2018Q3 | -290000 USD | ? USD |
| 2018Q2 | -6.1 million USD | ? USD |
| 2018Q1 | 2.4 million USD | ? USD |
| 2017Q4 | 2.4 million USD | ? USD |
| 2017Q3 | -6.1 million USD | ? USD |
| 2017Q2 | -8.4 million USD | ? USD |
| 2017Q1 | -11.7 million USD | ? USD |
| 2016Q4 | -5.5 million USD | ? USD |
| 2016Q3 | -6.9 million USD | ? USD |
| 2016Q2 | 5.4 million USD | ? USD |
| 2016Q1 | -16.5 million USD | ? USD |
| 2015Q4 | -19.7 million USD | -6.1 million USD |
| 2015Q3 | -18.0 million USD | 9.5 million USD |
| 2015Q2 | -15.7 million USD | 3.4 million USD |
| 2015Q1 | -10.5 million USD | 2.8 million USD |
| 2014Q4 | -8.0 million USD | 3.2 million USD |
| 2014Q3 | -6.2 million USD | 1.6 million USD |
| 2014Q2 | -19.9 million USD | 2.3 million USD |
| 2014Q1 | -2.5 million USD | 2.2 million USD |
| 2013Q4 | -48.5 million USD | 1.3 million USD |
| 2013Q3 | -9.3 million USD | 1.2 million USD |
| 2013Q2 | -9.6 million USD | ? USD |
| 2013Q1 | -9.3 million USD | ? USD |
| 2012Q4 | -3.8 million USD | 2.1 million USD |
| 2012Q3 | -6.3 million USD | ? USD |
| 2012Q2 | -196000 USD | ? USD |
| 2012Q1 | -24.8 million USD | ? USD |
| 2011Q4 | 1.6 million USD | ? USD |
| 2011Q3 | -5.5 million USD | ? USD |
| 2011Q2 | -1.4 million USD | ? USD |
| 2011Q1 | -1.8 million USD | 243000 USD |
| 2010Q4 | -1.8 million USD | ? USD |
| 2010Q3 | -4.1 million USD | ? USD |
| 2010Q2 | -2.1 million USD | ? USD |
| 2010Q1 | -3.9 million USD | ? USD |
| 2009Q4 | -6.1 million USD | 101000 USD |
| 2009Q3 | -3.0 million USD | ? USD |
| 2009Q2 | -5.1 million USD | ? USD |
| 2009Q1 | -4.2 million USD | ? USD |
| 2008Q4 | -4.0 million USD | ? USD |
| 2008Q3 | -3.4 million USD | ? USD |
| 2008Q2 | -4.3 million USD | ? USD |
| 2008Q1 | -2.6 million USD | ? USD |
| 2007Q4 | -2.6 million USD | ? USD |
| 2007Q3 | -2.8 million USD | ? USD |
| 2007Q2 | -4.8 million USD | ? USD |
| 2007Q1 | -1.4 million USD | ? USD |
| 2006Q4 | -766000 USD | ? USD |
SLS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -38.3 million USD | ? USD |
| 2022 | -40.7 million USD | 1.0 million USD |
| 2021 | -20.7 million USD | 7.6 million USD |
| 2020 | -16.8 million USD | 1900 USD |
| 2019 | -19.3 million USD | ? USD |
| 2018 | -27.7 million USD | ? USD |
| 2017 | -23.8 million USD | ? USD |
| 2016 | -23.5 million USD | ? USD |
| 2015 | -63.9 million USD | ? USD |
| 2014 | -36.6 million USD | 9.3 million USD |
| 2013 | -76.7 million USD | 2.5 million USD |
| 2012 | -35.0 million USD | 2.0 million USD |
| 2011 | -11.5 million USD | ? USD |
| 2010 | -12.0 million USD | ? USD |
| 2009 | -18.4 million USD | ? USD |
| 2008 | -14.4 million USD | ? USD |
| 2007 | -11.0 million USD | ? USD |
| 2006 | -2.4 million USD | ? USD |
SLS
Price: $1.35
52 week price:
Earnings Per Share: -1.34 USD
P/E Ratio: -0.50
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 183300
Ebitda: -4.4 millionMarket Capitalization: 76.5 million